Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

Albanell, 2001, Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839, Semin. Oncol., 28, 56, 10.1016/S0093-7754(01)90283-0 Anderson, 1990, Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors, Science, 250, 979, 10.1126/science.2173144 Arteaga, 2003, Targeting HER1/EGFR: A molecular approach to cancer therapy, Semin. Oncol., 30, 3, 10.1016/S0093-7754(03)70010-4 Bader, 1994, Nuclear accumulation of interferon gamma, Proc. Natl. Acad. Sci. USA, 91, 11831, 10.1073/pnas.91.25.11831 Barre, 2003, Opposite regulation of myc and p21waf1 transcription by STAT3 proteins, J. Biol. Chem., 278, 2990, 10.1074/jbc.M210422200 Bild, 2002, Cytoplasmic transport of Stat3 by receptor-mediated endocytosis, EMBO J., 21, 3255, 10.1093/emboj/cdf351 Bourguignon, 2002, Localizing the EGF receptor - Reply, Nat. Cell Biol., 4, E22, 10.1038/ncb0202-e22b Bowman, 2001, Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis, Proc. Natl. Acad. Sci. USA, 98, 7319, 10.1073/pnas.131568898 Bromberg, 1999, Stat3 as an oncogene, Cell, 98, 295, 10.1016/S0092-8674(00)81959-5 Chan, 2003, Receptors of glutamate and neurotrophin in vestibular neuronal functions, J. Biomed. Sci., 10, 577, 10.1007/BF02256307 Chou, 1984, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzyme Regul., 22, 27, 10.1016/0065-2571(84)90007-4 Cianchi, 2003, Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis, Am. J. Pathol., 162, 793, 10.1016/S0002-9440(10)63876-X Cianchi, 2004, Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer, Clin. Cancer Res., 10, 2694, 10.1158/1078-0432.CCR-03-0192 Coffer, 1995, EGF receptor deletions define a region specifically mediating STAT transcription factor activation, Biochem. Biophys. Res. Commun., 210, 74, 10.1006/bbrc.1995.1629 Cohen, 1982, Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver, Proc. Natl. Acad. Sci. USA, 79, 6237, 10.1073/pnas.79.20.6237 Cohen, 1982, A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles, J. Biol. Chem., 257, 1523, 10.1016/S0021-9258(19)68224-4 Craven, 2003, A decade of tyrosine kinases: from gene discovery to therapeutics, Surg. Oncol., 12, 39, 10.1016/S0960-7404(03)00004-5 Curtis, 1990, IL-1 and its receptor are translocated to the nucleus, J. Immunol., 144, 1295, 10.4049/jimmunol.144.4.1295 Darnell, 1994, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415, 10.1126/science.8197455 Dowlati, 2004, Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy, Mol. Cancer Ther., 3, 459, 10.1158/1535-7163.459.3.4 Ekmekcioglu, 2000, Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival, Clin. Cancer Res., 6, 4768 Fantappie, 2002, The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line, Hepatology, 35, 843, 10.1053/jhep.2002.32469 Fernandes, 1999, ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells, Int. J. Cancer, 83, 564, 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q Fu, 1999, From PTK-STAT signaling to caspase expression and apoptosis induction, Cell Death Differ., 6, 1201, 10.1038/sj.cdd.4400613 Gallo, 2002, Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas, Biochem. Biophys. Res. Commun., 299, 517, 10.1016/S0006-291X(02)02683-9 Garcia, 2001, Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells, Oncogene, 20, 2499, 10.1038/sj.onc.1204349 Grasl-Kraupp, 2002, A novel mechanism for mitogenic signaling via pro-transforming growth factor alpha within hepatocyte nuclei, Hepatology, 35, 1372, 10.1053/jhep.2002.33203 Hsiao, 2003, Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis, Br. J. Cancer, 89, 344, 10.1038/sj.bjc.6601003 Hu, 1992, Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors, Mol. Cell. Biol., 12, 981, 10.1128/MCB.12.3.981 Jadeski, 1999, Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors, Am. J. Pathol., 155, 1381, 10.1016/S0002-9440(10)65240-6 Jans, 1998, Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?, Bioessays, 20, 400, 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R Jans, 1997, The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro, FEBS Lett., 410, 368, 10.1016/S0014-5793(97)00622-4 Jenkins, 1995, Roles of nitric oxide in tumor growth, Proc. Natl. Acad. Sci. USA, 92, 4392, 10.1073/pnas.92.10.4392 Karni, 1999, Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors, Oncogene, 18, 4654, 10.1038/sj.onc.1202835 Khoury, 2003, Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma, Clin. Cancer Res., 9, 3692 Lala, 1998, Role of nitric oxide in tumor progression: lessons from experimental tumors, Cancer Metastasis Rev., 17, 91, 10.1023/A:1005960822365 Larkin, 2000, Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma, J. Interferon Cytokine Res., 20, 565, 10.1089/10799900050044769 Lin, 2001, Nuclear localization of EGF receptor and its potential new role as a transcription factor, Nat. Cell Biol., 3, 802, 10.1038/ncb0901-802 Liu, 2003, Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy, Neurobiol. Dis., 13, 109, 10.1016/S0969-9961(03)00010-X Lo, 2005, Novel prognostic value of nuclear EGF receptor in breast cancer, Cancer Res., 65, 338, 10.1158/0008-5472.338.65.1 Lynch, 2004, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N. Engl. J. Med., 350, 2129, 10.1056/NEJMoa040938 Maher, 1996, Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2, J. Cell Biol., 134, 529, 10.1083/jcb.134.2.529 Maida, 2002, Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway, Oncogene, 21, 4071, 10.1038/sj.onc.1205509 Marti, 1995, Acinar and cellular distribution and mRNA expression of the epidermal growth factor receptor are changed during liver regeneration, J. Hepatol., 23, 318 Marti, 1991, Localization of epidermal growth factor receptor in hepatocyte nuclei, Hepatology, 13, 15, 10.1002/hep.1840130104 Masuda, 2002, Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma, Cancer Res., 62, 3351 Mendelsohn, 2003, Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer, J. Clin. Oncol., 21, 2787, 10.1200/JCO.2003.01.504 Nakajima, 1996, A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells, EMBO J., 15, 3651, 10.1002/j.1460-2075.1996.tb00734.x Ni, 2001, gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase, Science, 294, 2179, 10.1126/science.1065412 Niu, 2002, Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis, Oncogene, 21, 2000, 10.1038/sj.onc.1205260 Offterdinger, 2002, c-erbB-3: a nuclear protein in mammary epithelial cells, J. Cell Biol., 157, 929, 10.1083/jcb.200109033 Paez, 2004, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science., 304, 1497, 10.1126/science.1099314 Park, 1996, In vitro activation of Stat3 by epidermal growth factor receptor kinase, Proc. Natl. Acad. Sci. USA, 93, 13704, 10.1073/pnas.93.24.13704 Podlecki, 1987, Nuclear translocation of the insulin receptor. A possible mediator of insulin’s long term effects, J. Biol. Chem., 262, 3362, 10.1016/S0021-9258(18)61511-X Raabe, 2004, Localization of neuregulin isoforms and erbB receptors in myelinating glial cells, Glia, 45, 197, 10.1002/glia.10311 Rakowicz-Szulczynska, 1988, Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro, Cancer Res., 48, 7200 Rao, 1993, Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase, Cancer Res., 53, 3449 Rao, 2002, Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor, Cancer Res., 62, 165 Reguly, 2003, In or out? The dynamics of Smad nucleocytoplasmic shuttling, Trends Cell Biol., 13, 216, 10.1016/S0962-8924(03)00075-8 Reilly, 2001, Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation, J. Cell Biol., 152, 1307, 10.1083/jcb.152.6.1307 Salzman, 1996, Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers, Am. J. Physiol., 270, G565 Shao, 2003, Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor, Cancer Res., 63, 3923 Shirogane, 1999, Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis, Immunity, 11, 709, 10.1016/S1074-7613(00)80145-4 Sinibaldi, 2000, Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling, Oncogene, 19, 5419, 10.1038/sj.onc.1203947 Sriuranpong, 2003, Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system, Cancer Res., 63, 2948 Subramaniam, 2002, Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha, J. Immunol., 169, 1959, 10.4049/jimmunol.169.4.1959 Subramaniam, 2001, Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence, J. Interferon Cytokine Res., 21, 951, 10.1089/107999001753289569 Turkson, 2000, STAT proteins: novel molecular targets for cancer drug discovery, Oncogene, 19, 6613, 10.1038/sj.onc.1204086 Vakkala, 2000, Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas, Clin. Cancer Res., 6, 2408 Violot, 2003, The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1, J. Virol., 77, 12507, 10.1128/JVI.77.23.12507-12522.2003 Wang, 1999, Differential expression of nitric oxide synthases in EGF-responsive mouse neural precursor cells, Cell Tissue Res., 296, 489, 10.1007/s004410051309 Wang, 2004, Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2, Cancer Cell, 6, 251, 10.1016/j.ccr.2004.07.012 Waugh, 2001, EGF receptors as transcription factors: ridiculous or sublime?, Nat. Cell Biol., 3, E209, 10.1038/ncb0901-e209 Wegenka, 1993, Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level, Mol. Cell. Biol., 13, 276, 10.1128/MCB.13.1.276 Wei, 2003, Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis, Oncogene, 22, 319, 10.1038/sj.onc.1206122 Wells, 2002, Signalling shortcuts: cell-surface receptors in the nucleus?, Nat. Rev. Mol. Cell Biol., 3, 697, 10.1038/nrm905 Williams, 2004, The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone, J. Cell Biol., 167, 469, 10.1083/jcb.200403155 Xie, 1994, Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation, Biochem. Biophys. Res. Commun., 203, 1589, 10.1006/bbrc.1994.2368 Yang, 2003, Independent and cooperative activation of chromosomal c-fos promoter by STAT3, J. Biol. Chem., 278, 15794, 10.1074/jbc.M213073200 Yu, 1995, Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein, Science, 269, 81, 10.1126/science.7541555 Zhang, 2003, Neurotrophin receptor immunostaining in the vestibular nuclei of rats, Neuroreport, 14, 851, 10.1097/00001756-200305060-00015 Zwaagstra, 2000, Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest, Exp. Cell Res., 258, 121, 10.1006/excr.2000.4905